For multi-location aesthetics platforms

Unlock same-store growth across the portfolio.

Akari helps multi-location aesthetics groups capture revenue already sitting inside their existing patient base using repeatable, measurable growth systems that can be tested at the location level and deployed across the platform.

  • No additional locations.
  • No additional ad spend required.
  • No discount-driven growth.

The premise

Growth at the portfolio level, not just marketing at the location level.

The opportunity

The patient base is already an asset.

Every acquired location adds more than equipment, providers and square footage. It adds an installed patient base.

Akari builds systems designed to increase the economic value of that existing asset through better monetization, reactivation, conversion, rebooking and frequency.

Operating thesis

  1. 01Acquire the patient
  2. 02Build the relationship
  3. 03Increase patient value
  4. 04Improve same-store economics

Growth without relying exclusively on increasing paid acquisition.

Case study One location Existing patient database

$59,000

Collected in 9 days

One location. Approximately 1,500 patient records. Existing patient database. No paid acquisition. No discounting.

The deployment

8
Emails
2
Text messages
9
Days
Existing
Patient list
Full-price
Offers
Campaign revenue, separated into what is directly attributable and what was observed afterward
Directly attributable
Days 1–9Direct campaign revenue. Collected from the campaign’s own offers$59K
Subsequent performance(Observed afterward. Reported, not attributed.)
Following 3 monthsSubsequent backend sales$64K
Following 3 monthsTwo record revenue months. Versus the same months a year earlier+$15K / +$22K
Combined observed revenue$160K
Methodology and attribution

Direct campaign revenue is cash collected from the campaign’s own offers during the nine-day window. It is the only figure we attribute to the campaign.

The backend sales and the two record months were observed in the three months that followed. We report them and do not claim them, because other drivers of revenue were not controlled for. Record-month gains are measured against the same months a year earlier.

One location and one campaign. A historical example, not a forecast.

The purpose of a portfolio pilot is not to extrapolate one case study across every location. It is to establish the economics inside your portfolio.

The portfolio pilot

Measure first. Deploy second. Scale what works.

Rather than begin with a portfolio-wide commitment, Akari starts with a controlled cohort of representative locations.

  1. 01

    Select

    3 representative locations

    Choose locations with different market characteristics, database sizes and operating profiles.

  2. 02

    Baseline

    Establish existing economics

    • Patient records
    • Historical revenue
    • Average patient value
    • Previous promotional performance
    • Capacity
    • Conversion
    • Rebooking
  3. 03

    Deploy

    Run the Akari system

    • Central strategy
    • Location-specific offers
    • Centralized execution
    • Consistent measurement
  4. 04

    Decide

    ScaleIterateStop

    Compare performance across the cohort and determine whether portfolio deployment is economically justified.

What we measure

Built around economics, not activity.

  • Collected revenue
  • Incremental revenue
  • Revenue per patient record
  • Purchase rate
  • Contribution margin
  • Redemption
  • Rebooking
  • Patient frequency
  • Capacity utilization
  • Location-level variance
  • Portfolio-level performance

Built for portfolio deployment

One operating framework. Location-level intelligence.

01

Centralized strategy

One operating framework across the portfolio.

02

Local execution

Offers adapt to market, patient database, service mix and available capacity.

03

Location-level measurement

Performance stays visible at the individual location level instead of disappearing into portfolio averages.

04

Repeatable rollout

Validate on a cohort. Standardize what works. Expand intentionally.

Akari Profit OS

Beyond a single revenue event.

A portfolio-level framework designed to improve the economics of the existing patient base throughout the year.

Database monetization
Seasonal and event-driven revenue campaigns, including the Akari Profit Engine.
Patient reactivation
Recover inactive patients already sitting inside the database.
Consult recovery
Improve conversion from interest and consultations into collected revenue.
Rebooking + frequency
Increase the frequency and consistency of existing patient relationships.
Patient value expansion
Develop additional revenue opportunities across services and treatment categories.

The economic thesis

You have already paid to acquire the patient.

Akari’s job is to increase the value of the relationship you’ve already acquired.

  1. Existing patient base
  2. Better conversion
  3. Greater frequency
  4. Stronger reactivation
  5. Better monetization
  6. Higher patient value
  7. Stronger same-store economics

Measure.Validate.Standardize.Scale.

Michael Kim Founder, Akari Growth

Leadership

Built by an operator.

Track record

  • 20+ years building and operating businesses
  • Multiple 7- and 8-figure businesses built
  • Former owner of a 7-figure performance marketing company
  • $500M+ in client online sales
  • Deep experience in direct response, lifecycle monetization, customer economics and growth strategy

Also: consulted with team members from Facebook, Google, Apple and Amazon, and personally hired by Russell Brunson, co-founder of ClickFunnels.

Who this is for

Designed for established platforms.

Akari Portfolio Programs are designed for multi-location aesthetics organizations with meaningful existing patient databases and leadership teams focused on improving same-store economics.

Potential fits include

  • PE-backed med spa platforms
  • Multi-location aesthetic practices
  • Aesthetic MSOs
  • Regional medical aesthetics groups
  • Growth-stage consolidators

Private discussion

Start with the economics.

A portfolio discussion begins with the current footprint, patient base and operating model. From there, we determine whether a controlled pilot is worth running.

No portfolio-wide commitment required.

Held in confidence.